氧化伊米达酸框架-8被封装在以Mo为基础的多氧甲酸盐的表面上,具有对大肠杆菌 (Escherichia coli) 的抗菌活性
Mariam M Abdelkhalek1, Aya M Mohamed2, Rehab Z Abdallah3
1Energy Materials Laboratory, Physics Department, School of Sciences and Engineering, The American University in Cairo New Cairo 11835 Egypt nageh.allam@aucegypt.edu.
Nanoscale advances
|June 27, 2024
概括
一种新型杂交材料,聚乙烯酸@氧化物伊米达酸框架-8 (PMA@ZIF-8),对大肠杆菌具有强大的抗菌特性. 这种协同作用的组合提供了增强的疗效和开发先进抗菌表面的潜力.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
- 生物医学工程 生物医学工程
背景情况:
- 细菌感染对全球健康构成重大威胁,需要创新的控制策略.
- 纳米孔隙材料为开发具有抗菌能力的表面提供了潜力.
- 机械杀菌效应是感染控制的一个新兴领域.
研究的目的:
- 为了合成和表征一种新型混合材料,聚乙烯酸@地质石化胺酸框架-8 (PMA@ZIF-8).
- 评估PMA@ZIF-8对大肠杆菌的抗菌疗效,包括其协同作用和杀菌动力学.
- 为了研究混合材料的潜在机械杀菌特性.
主要方法:
- 使用FESEM,EDS,XRD,FTIR和N2吸附的PMA@ZIF-8的合成和表征.
- 最低抑制度 (MIC) 和时间杀死曲线实验以评估抗菌活性.
- 密度函数理论 (DFT) 计算和埃尔曼试验以确定氧化纳米酶特性.
- 在涂层表面进行活/死测定,以确认机械杀菌效果.
主要成果:
- 与单个成分相比,PMA@ZIF-8显示出对大肠杆菌的抗菌性能优越,这表明它具有协同作用.
- 混合材料显示MIC减少了两倍,杀菌动力率增加了4.35倍.
- 在7小时内,PMA@ZIF-8实现了3日志的减少,比单独使用ZIF-8要快得多.
- 计算和实验数据证实PMA@ZIF-8是一种具有减少带隙的氧化纳米酶.
- 表面分析显示了纳米突起,与已确认的机械杀菌活性相关.
结论:
- 混合PMA@ZIF-8材料通过结合的氧化和机械杀菌机制表现出强大的抗菌活性.
- 这种协同作用的混合材料对开发先进的多功能抗菌表面具有显著的前景.
- 这些发现有助于推进抗击细菌感染的新策略.
更多相关视频
相关概念视频
01:18Surface Membrane Barriers
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:23Stringent Response in E. coli
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:24iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...